Abstract:Endothelial injury, characterized by an inflammatory response and increased permeability, is an initial stage of atherosclerosis (AS). Adenosine 5′-monophosphate (AMP), activated protein kinase (AMPK), and Nuclear Factor kappa B (NF-κB)/Yin Yang 1(YY1) signaling pathways play important roles in the process of endothelial injury. Berberine (BBR), a bioactive alkaloid isolated from several herbal substances, possesses multiple pharmacological effects, including anti-inflammatory, antimicrobial, antidiabetic, anticancer, and antioxidant activities. Previous studies showed a protective effect of berberine against endothelial injury. However, the underlying mechanism remains unclear. We explored the potential effect of BBR on TNF- (tumor necrosis factor-) α-induced injury of human umbilical endothelial cells (HUVECs) and studied its possible molecular mechanism. In the present study, HUVECs were divided into three groups. HUVEC viability was measured with Cell Counting Kit-8 assay. Extracellular lactic dehydrogenase (LDH) concentration was measured with LDH leakage assay. Endothelial microparticle (EMP) numbers were evaluated by flow cytometry analysis assay. The expression of proinflammatory cytokines was evaluated by Enzyme-Linked Immunosorbent Assay (ELISA). The mRNA expression of NF-κB and YY1 was detected by Real-Time PCR (RT-PCR). The protein expression of NF-κB, YY1, and AMPK was detected by immunofluorescence microscopy assay or western blot analysis. The results showed that LDH concentration, EMPs numbers, and the expression of proinflammatory cytokines (IL-6, IL-8, and IL-1β) increased in TNF-α-induced injured HUVECs, but ameliorated by BBR pretreatment. BBR pretreatment upregulated the expression of phosphorylated AMPK and downregulated the expressions of NF-κB and YY1 in injured HUVECs induced by TNF-α, which were offset by the AMPK inhibitor Compound C (CC). The results indicated that BBR protected against TNF-α-induced endothelial injury via the AMPK/NF-κB/YY1 signaling pathway.

Berberine Protects Human Umbilical Vein Endothelial Cells Against LPS-Induced Apoptosis by Blocking JNK-Mediated Signaling

Protective Effect of Berberine Against LPS-induced Endothelial Cell Injury Via the JNK Signaling Pathway and Autophagic Mechanisms

Puerarin protects human umbilical vein endothelial cells against high glucose-induced apoptosis by upregulating heme oxygenase-1 and inhibiting calpain activation.

Protective Effects of Berberine against Low-Density Lipoprotein (LDL) Oxidation and Oxidized LDL-Induced Cytotoxicity on Endothelial Cells

Berberine Protects against TNF-α-Induced Injury of Human Umbilical Vein Endothelial Cells via the AMPK/NF-κB/YY1 Signaling Pathway

Berberine Protects Against Palmitate-Induced Endothelial Dysfunction: Involvements of Upregulation of AMPK and Enos and Downregulation of NOX4

Pretreatment with Berberine and Yohimbine Protects Against Lps-Induced Myocardial Dysfunction Via Inhibition of Cardiac I-Kappa B Alpha Phosphorylation and Apoptosis in Mice

Yohimbine Enhances Protection Of Berberine Against Lps-Induced Mouse Lethality Through Multiple Mechanisms

Berberine Protects Against Lipopolysaccharide-Induced Intestinal Injury in Mice Via Alpha 2 Adrenoceptor-Independent Mechanisms

Berberine Suppresses Leukocyte Adherence by Downregulating CX3CL1 Expression and Shedding and ADAM10 in Lipopolysaccharide-Stimulated Vascular Endothelial Cells

Mechanisms Underlying the Protection of Berberine Against Liver Injury Induced by Lipopolysaccharide in Mice

Berberine Protects Mesenchymal Stem Cells Against Hypoxia-Induced Apoptosis in Vitro

Berberine ameliorates lipopolysaccharide-induced acute lung injury via the PERK-mediated Nrf2/HO-1 signaling axis.

Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway.

Metabolomics Profiling Reveals Berberine-Inhibited Inflammatory Response in Human Gingival Fibroblasts by Regulating the LPS-induced Apoptosis Signaling Pathway

Berberine Inhibits Low Shear Stress-Induced Vascular Endothelial Inflammation Via Decreasing Phosphorylation of Akt and IRF3

Berberine inhibits cytosolic phospholipase A(2) and protects against LPS-induced lung injury and lethality independent of the alpha(2)-adrenergic receptor in mice

Berberine attenuates uric acid-induced cell injury by inhibiting NLRP3 signaling pathway in HK-2 cells

Activation Of Amp-Activated Protein Kinase Is Required For Berberine-Induced Reduction Of Atherosclerosis In Mice: The Role Of Uncoupling Protein 2

Berberine inhibits proliferation and apoptosis of vascular smooth muscle cells induced by mechanical stretch via the PDI/ERS and MAPK pathways

Puerarin Prevents Vascular Endothelial Injury Through Suppression of NF-κB Activation in LPS-challenged Human Umbilical Vein Endothelial Cells